G. Möslein

M. Kloor, M. von Knebel Doeberitz, M. Loeffler, 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Guidelines for the clinical management of Lynch

P. Møller, G. Capellá, J. Mecklin, 2007 .

No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies.

M. Kloor, M. von Knebel Doeberitz, C. Strassburg, 2018, Gastroenterology.

Endoscopic management of duodenal adenomatosis in familial adenomatous polyposis—A case‐based review

G. Möslein, P. Siersema, M. V. van Kouwen, 2021, United European gastroenterology journal.

[Desmoid tumors in patients with familial adenomatous polyposis (FAP). Clinical and therapeutic observations from the Heidelberg polyposis register].

H. Buhr, C. Herfarth, G. Möslein, 1995, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.

D. Bishop, R. Scott, D. Evans, 2008, The New England journal of medicine.

The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) – Results of an international collaborative study

T. Ørntoft, C. Boland, S. Thibodeau, 2001, Familial Cancer.

Lynch Syndrome - how can we improve the Clinical Awareness?

G. Möslein, A. Fürst, R. Schneider, 2011 .

Colorectal Cancer Clinical Oncology

G. Möslein, 2014 .

Identification of Patients with Pancreatic Cancer by Electron Paramagnetic Resonance Spectroscopy of Fatty Acid Binding to Human Serum Albumin.

M. Gelos, G. Möslein, D. Hinderberger, 2020, ACS pharmacology & translational science.

The inframe MSH2 codon 596 deletion is linked with HNPCC and associated with lack of MSH2 protein in tumours

K. Heimdal, P. Møller, A. Lindblom, 2004, Familial Cancer.

Prediction of the outcome of genetic testing in HNPCC kindreds using the revised Amsterdam criteria and immunohistochemistry

P. Møller, R. Fodde, W. Müller, 2004, Familial Cancer.

Extraintestinal polyps in Peutz-Jeghers syndrome: presentation of four cases and review of the literature

G. Möslein, J. Trojan, V. Schumacher, 2000, International Journal of Colorectal Disease.

Management of desmoid tumors in patients after ileal pouch-anal anastomosis for familial adenomatous polyposis

G. Möslein, P. Sagar, R. Dozois, 1998, Diseases of the colon and rectum.

[Rectal carcinomas in HNPCC].

H. Nelson, G. Möslein, R. Dozois, 1998, Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress.

Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report

Aung Ko Win, M. von Knebel Doeberitz, B. Bonanni, 2021, European journal of cancer.

Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

Aung Ko Win, P. Møller, E. Hovig, 2019, Genetics in Medicine.

Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report

Aung Ko Win, M. von Knebel Doeberitz, B. Bonanni, 2020, Genetics in Medicine.

Letter to the Editor-Recent advances in Lynch syndrome

P. Møller, J. Mecklin, J. Burn, 2020, Familial Cancer.

Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.

M. Kloor, M. von Knebel Doeberitz, A. Stenzinger, 2020, Gastroenterology.

Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report

M. Kloor, P. Møller, E. Hovig, 2019, Hereditary Cancer in Clinical Practice.

Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report

P. Møller, E. Hovig, S. Nakken, 2017, Hereditary cancer in clinical practice.

Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database

P. Møller, E. Hovig, S. Nakken, 2016, Gut.

Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report

P. Møller, E. Hovig, S. Nakken, 2017, Hereditary Cancer in Clinical Practice.

European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender

M. Kloor, P. Møller, Ionut Negoi, 2021, The British journal of surgery.

Correction: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

Aung Ko Win, P. Møller, E. Hovig, 2020, Genetics in Medicine.

Gender-Specific Aspects in Gastrointestinal Medicine and Surgery

S. Oertelt-Prigione, B. Rau, G. Möslein, 2014, Visceral Medicine.

Identi ﬁ cation of Patients with Pancreatic Cancer by Electron Paramagnetic Resonance Spectroscopy of Fatty Acid Binding to Human Serum Albumin

M. Gelos, G. Möslein, D. Hinderberger, 2020 .

STK11 genotyping and cancer risk in Peutz-Jeghers syndrome

G. Möslein, B. Royer-Pokora, B. Leube, 2005, Journal of Medical Genetics.

Nuclear Pedigree Criteria of Suspected HNPCC

J. Kładny, A. Jakubowska, J. Lubiński, 2003, Hereditary Cancer in Clinical Practice.

Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer

P. Møller, E. Hovig, S. Nakken, 2022 .

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

P. Møller, G. Capellá, A. Lindblom, 2013, Gut.

Attenuated familial adenomatous polyposis: results from an international collaborative study

I. Tomlinson, I. Christensen, S. Bülow, 2010, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Clinical implications of molecular diagnosis in hereditary nonpolyposis colorectal cancer.

G. Möslein, 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Clinical Aspects of Hereditary Nonpolyposis Colorectal Cancer

G. Möslein, T. Vogel, R. Krause‐Paulus, 2000, Annals of the New York Academy of Sciences.

Salvage surgery for continent ileostomies (CI) after a first successful revision: more long-term blame on the reservoir than the nipple valve

G. Möslein, K. Ecker, Mathias Tönsmann, 2021, International Journal of Colorectal Disease.

Guidelines for the clinical management of familial adenomatous polyposis (FAP)

P. Møller, G. Capellá, S. Tejpar, 2008, Gut.

Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome

S. Gruber, R. Scott, R. Houlston, 2006, Clinical Cancer Research.

Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC)

P. Møller, P. Hutter, W. Foulkes, 2005, Genes, chromosomes & cancer.

The “unnatural” history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillance

M. Kloor, M. von Knebel Doeberitz, H. Brenner, 2020, International journal of cancer.

Microsatellite instability of selective target genes in HNPCC-associated colon adenomas

Holger Vogelsang, Matthias Kloor, M. Kloor, 2005, Oncogene.

Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH.

Renée X de Menezes, Riccardo Fodde, Hans Morreau, 2004, Nucleic acids research.

European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender

M. Kloor, M. von Knebel Doeberitz, P. Møller, 2020, The British journal of surgery.

Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial

D. Bishop, R. Scott, D. Evans, 2020, The Lancet.

Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous Polyposis.

M. Nöthen, G. Kristiansen, A. Tafazzoli, 2016, American journal of human genetics.

A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis

D. Bishop, D. Evans, J. Mathers, 2011, Cancer Prevention Research.

Surgical considerations in FAP-related pouch surgery: Could we do better?

G. Möslein, 2016, Familial Cancer.

Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families

J. Gebert, P. Propping, G. Möslein, 2001, Gut.

No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study

Aung Ko Win, M. von Knebel Doeberitz, B. Bonanni, 2021, Journal of clinical medicine.

Chromosomal instability in MYH- and APC-mutant adenomatous polyps.

H. Morreau, R. Fodde, J. Boer, 2006, Cancer research.

Characteristics of Early-Onset vs Late-Onset Colorectal Cancer: A Review.

Swati G. Patel, M. Hoffmeister, J. Monson, 2021, JAMA surgery.

Familial endometrial cancer in female carriers of MSH6 germline mutations

P. Møller, H. Meijers-Heijboer, R. Hofstra, 1999, Nature Genetics.

The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome

P. Møller, H. Kitchener, U. Menon, 2019, Genetics in Medicine.

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.

J. Klijn, A. Hollestelle, M. Schutte, 2003, American journal of human genetics.

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)

P. Møller, G. Capellá, J. Mecklin, 2007, Journal of Medical Genetics.

The Management of Peutz–Jeghers Syndrome: European Hereditary Tumour Group (EHTG) Guideline

A. Wagner, M. Bruno, I. Winship, 2021, Journal of clinical medicine.

Management of Hamartomatous Polyps

G. Möslein, P. Ambe, 2020 .

Surgical management of hereditary colorectal cancer

G. Möslein, P. Ambe, 2018, Mini-invasive Surgery.

Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue

C. Sutter, G. Evans, J. Gebert, 2004, Human mutation.

Familial adenomatous polyposis: Aberrant splicing due to missense or silent mutations in the APC gene

K. Schulmann, P. Propping, S. Aretz, 2004, Human mutation.

Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444.

G. Thomas, P. Propping, S. Olschwang, 1995, Human molecular genetics.

Comparative in silico analyses and experimental validation of novel splice site and missense mutations in the genes MLH1 and MSH2

G. Möslein, C. Konermann, H. Schaal, 2009, Journal of Cancer Research and Clinical Oncology.

Is HLA type a possible cancer risk modifier in Lynch syndrome?

M. Kloor, M. von Knebel Doeberitz, P. Møller, 2022, International journal of cancer.

Prophylactic surgery in familial adenomatous polyposis (FAP)—a single surgeon’s short- and long-term experience with hand-assisted proctocolectomy and smaller J-pouches

G. Möslein, R. Schneider, C. Jakobeit, 2015, International Journal of Colorectal Disease.

Continent ileostomy: short- and long-term outcomes of a forgotten procedure

G. Möslein, K. Ecker, N. Ecker, 2021, BJS open.

[Familial adenomatous polyposis. Initial experiences with the Heidelberg polyposis register].

H. Buhr, C. Herfarth, G. Möslein, 1992, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

Feasibility and Diagnostic Utility of Video Capsule Endoscopy for the Detection of Small Bowel Polyps in Patients with Hereditary Polyposis Syndromes

K. Schulmann, S. Hollerbach, W. Schmiegel, 2005, The American Journal of Gastroenterology.

Initial experience with taTME in patients undergoing laparoscopic restorative proctocolectomy for familial adenomatous polyposis

G. Möslein, H. Zirngibl, P. Ambe, 2017, Techniques in Coloproctology.

Recommendations to improve identification of hereditary and familial colorectal cancer in Europe

P. Møller, G. Capellá, A. Lindblom, 2010, Familial Cancer.

G. Möslein, Steffen Hoppe, R. Schneider, 2015, Familial Cancer.

Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up

D. Bishop, J. Rashbass, A. Lindblom, 2022, Cancer prevention research.

Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study.

Katherine M. Tucker, Aung Ko Win, Swati G. Patel, 2021, The Lancet. Oncology.

Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

Aung Ko Win, P. Møller, E. Hovig, 2019, Genetics in Medicine.

Age‐dependent performance of BRAF mutation testing in Lynch syndrome diagnostics

M. Kloor, M. von Knebel Doeberitz, H. Brenner, 2020, International journal of cancer.

High frequency of microsatellite instability and loss of mismatch‐repair protein expression in patients with double primary tumors of the endometrium and colorectum

H. Olsson, G. Möslein, M. Nilbert, 2002, Cancer.

Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer

P. Propping, M. Knapp, G. Möslein, 1994, The Lancet.

Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studies

Johannes H. Hegemann, Christoph Engel, Robin Küppers, 2011, Familial Cancer.

Prophylactic transanal irrigation for low anterior resection syndrome following rectal resection

G. Möslein, G. Liebig-Hörl, W. Kneist, 2017, coloproctology.

Empfehlungen zur Früherkennung, Risikoreduktion, Überwachung und Therapie bei Patienten mit Lynch-Syndrom

M. Kloor, C. Strassburg, M. Loeffler, 2019, Zeitschrift für Gastroenterologie.

Genderspezifische Aspekte des Lynch-Syndroms – Ein Update

G. Möslein, A. Fürst, R. Schneider, 2015, Zeitschrift für Gastroenterologie.

[Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].

J. Rüschoff, R. Büttner, A. Tannapfel, 2014, Zentralblatt fur Chirurgie.

Das Lynch-Syndrom

M. Kloor, G. Möslein, A. Fürst, 2012, coloproctology.

Lynch syndrome: clinical, pathological, and genetic insights

M. Kloor, G. Möslein, A. Fürst, 2012, Langenbeck's Archives of Surgery.

Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report

M. Kloor, P. Møller, E. Hovig, 2019, Hereditary Cancer in Clinical Practice.

Preventive surgery for colon cancer in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer syndrome

H. Schackert, H. Saeger, G. Möslein, 2003, Langenbeck's Archives of Surgery.

The Human Variome Project

Sue Povey, Johan T den Dunnen, Anthony J Brookes, 2008, Science.

Intestinal Ostomy Classification , Indications , Ostomy Care and Complication Management

G. Möslein, S. Odeh, P. Ambe, 2018 .

Intestinal Ostomy.

G. Möslein, S. Odeh, H. Zirngibl, 2018, Deutsches Arzteblatt international.

[Report on the workshop "workflow rectal cancer II" in Burghausen].

A. Tannapfel, G. Möslein, W. Schwenk, 2007, Zentralblatt fur Chirurgie.

Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report

M. Kloor, P. Møller, E. Hovig, 2019, Hereditary cancer in clinical practice.

BRAFmutation testing of MSI CRCs in Lynch syndrome diagnostics: performance and efficiency according to patient’s age

M. Kloor, M. von Knebel Doeberitz, H. Brenner, 2019 .

Gender-Specific Aspects of Lynch Syndrome and Familial Adenomatous Polyposis

G. Möslein, A. Fürst, R. Schneider, 2014, Visceral Medicine.

Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study

M. Kloor, M. von Knebel Doeberitz, C. Strassburg, 2020, BMC Cancer.

[Prophylactic surgery for hereditary non-polyposis colorectal cancer].

C. Ohmann, G. Möslein, M. Wenzel, 2005, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

Female Representation and Position Based on Facts and Members Views in the European Society of Coloproctology

G. Möslein, A. Ioannidis, D. Keller, 2020, Diseases of the colon and rectum.

[Quality indicators for diagnostic and therapy of rectal carcinoma].

A. Tannapfel, G. Möslein, W. Schwenk, 2007, Zentralblatt fur Chirurgie.

Comparing ‘Twitter’ polls results with an online survey on surgeons perspectives for the treatment of rectal cancer

J. Monson, C. Verschoor, M. Raval, 2020, BMJ Innovations.

The different immune profiles of normal colonic mucosa in cancer-free Lynch syndrome carriers and Lynch syndrome colorectal cancer patients.

M. Kloor, M. von Knebel Doeberitz, D. Bishop, 2021, Gastroenterology.

Conversion of ileo‐pouch anal anastomosis to continent ileostomy: strategic surgical considerations and outcome

G. Möslein, K. Ecker, N. Ecker, 2022, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Variant profiling of colorectal adenomas from three patients of two families with MSH3-related adenomatous polyposis

M. Odenthal, M. Peifer, A. Hillmer, 2021, PloS one.

Routine Virtual Ileostomy Following Restorative Proctocolectomy for Familial Adenomatous Polyposis

G. Möslein, H. Zirngibl, P. Ambe, 2018, World Journal of Surgery.

STK11 status and intussusception risk in Peutz-Jeghers syndrome

S. Gruber, R. Scott, R. Houlston, 2006, Journal of Medical Genetics.

[Surgical aspects of indications and techniques for adenomatous polyposis variants].

G. Möslein, 2016, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

Aalborg Universitet Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by overdiagnosis ; A prospective Lynch syndrome database report

M. Kloor, P. Møller, E. Hovig, 2019 .

[Comparison of different stool tests for the detection of cancer of the colon].

G. Möslein, M. Jonas, A. Hansmann, 2005, Deutsche Medizinische Wochenschrift.

Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous Polyposis.

M. Nöthen, G. Kristiansen, A. Tafazzoli, 2016, American journal of human genetics.

A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis

D. Bishop, J. Mathers, R. Fodde, 2011, Cancer Prevention Research.